Guardant Health, Inc. (GH)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Guardant Health, Inc. (GH)
Company Performance

Current Price

as of Nov 25, 2024

$35.40

P/E Ratio

N/A

Market Cap

$4.37B

Description

Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2011 and is headquartered in Palo Alto, CA.

Metrics

Overview

  • HQPalo Alto, CA
  • SectorHealth Services
  • IndustryMedical/Nursing Services
  • TickerGH
  • Price$35.4+8.42%

Trading Information

  • Market cap$4.37B
  • Float95.37%
  • Average Daily Volume (1m)2,376,719
  • Average Daily Volume (3m)2,119,275
  • EPS-$4.24

Company

  • Revenue$692.26M
  • Rev growth (1yr)33.87%
  • Net income-$107.75M
  • Gross margin61.10%
  • EBITDA margin-55.74%
  • EBITDA-$106.73M
  • EV$3.16B
  • EV/Revenue4.57
  • P/EN/A
  • P/S6.29
  • P/BN/A
Documents